Sol-Gel将向PellePharm支付470万美元的预付款,以及高达600万美元的开发和NDA验收里程碑,以及高达6400万美元的商业里程碑和分成。
Patidegib被Sol-Gel指定为SGT-610,用于治疗Go...查看全文
$Sol-Gel Technologies Ltd.(SLGL)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-11-01 AccNo: 0001178913-18-002779 Size: 150 KB 网页链接
$Sol-Gel Technologies Ltd.(SLGL)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-09-17 AccNo: 0001178913-18-002537 Size: 34 KB 网页链接
$Sol-Gel Technologies Ltd.(SLGL)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-09-04 AccNo: 0001178913-18-002476 Size: 45 KB 网页链接
$Sol-Gel Technologies Ltd.(SLGL)$ 6-K/A [Amend] - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-08-20 AccNo: 0001178913-18-002424 Size: 220 KB 网页链接
$Sol-Gel Technologies Ltd.(SLGL)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-08-15 AccNo: 0001178913-18-002411 Size: 151 KB 网页链接
$Sol-Gel Technologies Ltd.(SLGL)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-08-08 AccNo: 0001178913-18-002330 Size: 130 KB 网页链接
$Sol-Gel Technologies Ltd.(SLGL)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-06-19 AccNo: 0001178913-18-001931 Size: 42 KB 网页链接
$Sol-Gel Technologies Ltd.(SLGL)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-06-06 AccNo: 0001178913-18-001871 Size: 2 MB 网页链接
$Sol-Gel Technologies Ltd.(SLGL)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-05-23 AccNo: 0001178913-18-001735 Size: 14 KB 网页链接
$Sol-Gel Technologies Ltd.(SLGL)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2018-05-23 AccNo: 0001178913-18-001735 Size: 14 KB 网页链接